Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|May 13, 2016
Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysisChanghoon Yoo, Min-Hee Ryu, Young-Soon Na, et al.
The Journal of General Virology|May 29, 2004
Nef from a primary isolate of human immunodeficiency virus type 1 lacking the EE(155) region shows decreased ability to down-regulate CD4Young-Soon Na, Keejung Yoon, Jeong-Gu Nam, et al.
Toxicological Research|November 27, 2013
Antifungal Effect of Brachyglottis repanda Ethanol ExtractChan Nam Yook, Young Soon Na, Hwa Jung Choi, et al.
Brain Research|November 8, 2006
Alpha-synuclein enhances dopamine D2 receptor signalingSung Jae Kim, Sung Yul Kim, Young-Soon Na, et al.
Biochemical and Biophysical Research Communications|August 2, 2020
The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion geneWoo-Cheol Cho, Young-Kyoung Shin, Young-Soon Na, et al.
The Journal of Gene Medicine|January 8, 2003
Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndromeYoungtae Hong, Seung Shin Yu, Jong-Mook Kim, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 23, 2020
Clinical implications of neutrophil-to-lymphocyte ratio and MDSC kinetics in gastric cancer patients treated with ramucirumab plus paclitaxelHyung-Don Kim, Min-Hee Ryu, Sangsoon Yoon, et al.
Cancer Letters|December 17, 2013
Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatasesJong Hyun Lee, Shu Yuan Chiang, Dongwoo Nam, et al.
BMC Cancer|April 18, 2015
Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpressionJi Hyun Park, Min-Hee Ryu, Young Soo Park, et al.
Cancer Letters|December 3, 2010
Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathwayHyun Jung Kim, Sung-Moo Kim, Kyung-Ran Park, et al.
Pageof 3